chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a medical assistant concerning an unspecified patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On an unknown date from 02-APR-2018 to 15-MAY-2018, the patient was vaccinated with an improperly stored dose of PROQUAD (Lot #: N021728, Exp Date:06-FEB-2019) (Lot#: N022972, Exp Date:19-FEB-2019), (Lot#: N029878, Exp Date: 22-APR-2019) or (Lot#: N025929 , Exp Date: 18-MAR-2019) for prophylaxis, which had a temperature excursion of 6.1F for 5 minutes. Previous temperature excursion was 5.9 F for 45 minutes. The digital data logger was involved in recording the temperature excursion. The vaccine was reconstituted with properly stored dose of sterile diluent (MERCK) (no more information was provided). No adverse effect was reported. No product quality complaint was involved. This is one of the several reports from the same source. Sender's Comments: US-009507513-1805USA006787: Original Case: 1805USA006787; US-009507513-1805USA009900: Original Case: 1805USA006787; US-009507513-1805USA009901: Original Case: 1805USA006787; US-009507513-1805USA009902: Original Case: 1805USA006787; US-009507513-1805USA009903: Original Case: 1805USA006787; US-009507513-1805USA009904: Original Case: 1805USA006787; US-009507513-1805USA009905: Original Case: 1805USA006787; US-009507513-1805USA009906: Original Case: 1805USA006787; US-009507513-1805USA009907: Original Case: 1805USA006787; US-009507513-1805USA009908: Original Case: 1805USA006787; US-009507513-1805USA009909: Original Case: 1805USA006787; US-009507513-1805USA009910: Original Case: 1805USA006787; US-009507513-1805USA009911: Original Case: 1805USA006787; US-009507513-1805USA009912: Original Case: 1805USA006787; US-009507513-1805USA009913: Original Case: 1805USA006787; US-009507513-1805USA009914: Original Case: 1805USA006787; US-009507513-1805USA009915: Original Case: 1805USA006787; US-009507513-1805USA009916: Original Case: 1805USA006787; US-009507513-1805USA009917: Original Case:1805USA006787; US-009507513-1805USA009918: Original Case: 1805USA006787; US-009507513-1805USA009919: Original Case: 1805USA006787; US-009507513-1805USA009920: Original Case: 1805USA006787; US-009507513-1805USA009921: Original Case: 1805USA006787; US-009507513-1805USA009922: Original Case: 1805USA006787; US-009507513-1805USA009923: Original Case: 1805USA006787; US-009507513-1805USA009924: Original Case: 1805USA006787; US-009507513-1805USA009925: Original Case: 1805USA006787; US-009507513-1805USA009926: Original Case: 1805USA006787; US-009507513-1805USA009927: Original Case: 1805USA006787; US-009507513-1805USA009928: Original Case: 1805USA006787; US-009507513-1805USA009929: Original Case: 1805USA006787; US-009507513-1805USA009930: Original Case: 1805USA006787; US-009507513-1805USA009931: Original Case: 1805USA006787; US-009507513-1805USA009932: Original Case: 1805USA006787; US-009507513-1805USA009933
Body ache, sensitive skin, fever, chills, fatigue resolved in 24-36 hrs
Swollen leg after immunization.  Follow up on 10/28/04 states: "Right leg has site problem."
syncope,  followed by profuse sweating, patient fainted twice., very low blood pressure, severe migraine and vomiting  EMS called after prolong time of syncope and vomiting.  Patient refused travel to ER.  I followed up a call to the patient later in the day and patient was tired but had fully recovered.
itchy skin; itchy throat; itchy lips; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy skin), THROAT IRRITATION (itchy throat) and LIP PRURITUS (itchy lips) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 27-Mar-2021, the patient experienced PRURITUS (itchy skin), THROAT IRRITATION (itchy throat) and LIP PRURITUS (itchy lips). At the time of the report, PRURITUS (itchy skin), THROAT IRRITATION (itchy throat) and LIP PRURITUS (itchy lips) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment information was not provided.
Pain in arm,; Numbness down hand; Nauseaus; Dizzy; Triggered migraine; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 09Apr2021 at 10:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications taken within two weeks prior to the vaccination included meloxicam (MOBIC), bupropion hydrochloride (WELLBUTRIN), amlodipine (MANUFACTURER UNKNOWN), vitamin d nos (VITAMIN D), cyanocobalamin (VITAMIN B12) and ascorbic acid (VITAMIN C) all from unknown date for unknown indication. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 13:15, the patient experienced pain in arm, numbness down her hand, nauseaus, dizzy and triggered migraine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events pain in arm, numbness down her hand, nauseaus, dizzy, and triggered migraine was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
The pt experienced hives on the trunk of body, redness, itching, raised blotches, rash, approximately 12 hours post vax, Treated with hydrocortisone cream
Patient states reported sustained soreness in his left arm beginning the day after his vaccination, and continuing through today. He is uncertain if the soreness he is experiencing today is related to the vaccine, or if other causes may be contributing. He is scheduled for an MRI to identify the source of his continued pain.
Shot was administered on 2/27/21 and 3/20/21 at the same location, by the same nurse. She was administering most of the shots while I was there (both times). She pinched my skin and barely injected the needle (subcutaneously).  I felt nothing either time, no side effects. I am 5'4", 185 lbs. I called today and the nurse told me, "I sometimes give a shot that way to skinny people in order to not hit bone". I explained to her that I am not skinny. I saw her give the shot to the individual before me the same way. We were all in the high risk groups those days. The nurse told me to contact the health department. I did, and I first got a text telling me to contact rep, they could not do anything. I have since contacted the State Dept. of Health. My concern
Patient stated he has been very tired and run down ever since he got the shot.  He asked if that was normal.  I said usually people only feel it for 1 to 2 days but if it's not getting better he should follow up with his Dr.
Breakthrough COVID infection. Symptoms of cough, shortness of breath, and nausea beginning 11/25/2022. Positive test collected 12/03/2022.
This spontaneous report was received from a medical assistant regarding a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On 16-JAN-2015, the patient was vaccinated with the first dose of RECOMBIVAX HB (dose, route, lot # and expiration date were not reported). On 16-FEB-2015, the patient was vaccinated with the second dose of RECOMBIVAX HB (dose, route, lot # and expiration date were not reported). On 17-MAR-2015, the patient was vaccinated with the third dose of RECOMBIVAX HB (dose and route were not reported, lot # K020218, expiration date 24-OCT-2016), what was outside of the recommendations per the RECOMBIVAX HB prescribing information. There was no adverse effect reported. Additional information has been requested.
A report has been received from a Health Professional concerning a Child, subject of unknown gender, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started during Oct-2013. Inadvertently got FLUMIST in the patient's eyes which started during Oct-2013. The outcome of the event of inadvertently got FLUMIST in eyes is unknown. The report was considered to be non-serious by the reporter.
suspected vaccination failure; still got them; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient still got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Dermatographic urticaria: 13 days after Moderna booster, transient itchy hives that travel all over and affect scalp, neck, face, trunk, abdomen, joints, and feet. Particularly bad at pressure points and close-fitting clothing, worsen with itching.
This medically confirmed spontaneous report (initial receipt: 26-Feb-2016) concerns a 35 year-old female patient. On 07-Oct-2015, the patient received AFLURIA (batch number U55406; expiry date: 30-Jun-2016 yet reported as 12-Jun-2016) 0.5mL via the intramuscular route. The AFLURIA vaccine was stored at 0.6 to 1.1 degrees Celsius (reported as 33-34 degrees Fahrenheit) multiple times. The last excursion was 0 degrees Celsius (reported as 32 degrees Fahrenheit) for no more than 24 hours. The outcome was not reported.
Got a little itchy, pink again; Little raised at injection site; Some pinkness at injection spot, little pink; Arm sore; Can not lift the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm sore), LIMB DISCOMFORT (Can not lift the arm), VACCINATION SITE DISCOLOURATION (Some pinkness at injection spot, little pink), VACCINATION SITE PRURITUS (Got a little itchy, pink again) and VACCINATION SITE SWELLING (Little raised at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M120A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm sore) and LIMB DISCOMFORT (Can not lift the arm). On 02-Feb-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Some pinkness at injection spot, little pink) and VACCINATION SITE SWELLING (Little raised at injection site). On 07-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Got a little itchy, pink again). At the time of the report, PAIN IN EXTREMITY (Arm sore), LIMB DISCOMFORT (Can not lift the arm), VACCINATION SITE DISCOLOURATION (Some pinkness at injection spot, little pink), VACCINATION SITE PRURITUS (Got a little itchy, pink again) and VACCINATION SITE SWELLING (Little raised at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided by the reporter.  No treatment information provided by the reporter.  The patient stated that she was feeling fine.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: NNI- AE contact information updated
Approximately 10 min after receiving vaccine, patient obtained a headache proceeding with tingling in both hands, difficulty swallowing, and feeling funny. She states as soon as she got it she developed an immediate headache, on her drive home she became lightheaded and had pins and needles sensation in her face and got a strange aura that lasted all her way home.  She said for a while she felt like she couldn't swallow.  She feels that she might have had a panic attack versus an adverse reaction to the vaccine and is declining any further evaluation.
Stomach pain; Vomiting; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 13-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EW0168) via an unspecified route of administration in the left arm on 23May2021 at 12:30 (at the age of 13-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24May2021 at 21:00 the patient experienced stomach pain, vomiting, diarrhea, for more than 4 hours. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event stomach pain, vomiting, diarrhea, for more than 4 hours was recovering.   No follow-up attempts are needed. No further information is expected.
The needle of the syringe was inserted into the arm of the patient and when  the plunger of the syringe was pressed the vaccine sprayed on the patient's arm.  This appeared to be because of a malfunction of the syringe.  There was no vaccine that exited through the arm into the needle.   New syringe and vaccine were collected and administered.
fever 103;diarrrhea x 4d;vomiting x1d;crying >2hr;
patient had some of the Shingrix vaccine leaked out due to a faulty needle; Inadvertent exposure to vaccine; Exposure via skin contact; This case was reported by a pharmacist via call center representative and described the occurrence of accidental underdose in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced accidental underdose, inadvertent exposure to vaccine and exposure via skin contact. On an unknown date, the outcome of the accidental underdose, inadvertent exposure to vaccine and exposure via skin contact were unknown.  Additional details were provided as follows:  The age at vaccination was not reported.  The pharmacist reported that some of the Shingrix vaccine leak due to faulty needle and patient exposed to vaccine, which led to accidental underdose, inadvertent exposure to vaccine and exposure via skin contact.  The reporter was distress and requested agent to provide medical information.  The patient's information, vaccination details or any other details was not collected.  No other information was provided.
pt recvd vax; ha, n for 2 days p/ dose 1;
I experienced severe weakness of both upper and lower extremities without any pain.  there was nbo shortness of breath or any signs of anaphylaxis. When I had Covid 19 disease in October 2020 ,I had a similar reaction resulting in loss of musculoskeletal control of both upper and lower extremities. I recovered completely after 6 days of hospitalization. During the hospitalization I lost 30lbs. It took 6 weeks of self administered PT to return to normal strength. The day after my Booster inj. #3 i had muscularweakness accompanied with chills which was limited to 5 hours duration.. The reason I am contacting CDC is the question of having a repeat vaccine sometime in the future. I contacted an Infectious  Disease specialist friend who suggested that I report the incident. I have never had a similar reaction to any other vaccine. I have been in excellent health all my life.
Case number PHEH2014US018793, is an initial spontaneous report from a nurse received on 18 Sep 2014. This report refers to a 14-year-old male patient. Past medical history and concomitant medication was not reported. The patient received only Men CWY liquid conjugate component of MENVEO (batch number: X14031) without being reconstituted with Men A lyophilized conjugate component intramuscularly on 18 Sep 2014. No adverse reaction reported following this medication error (inappropriate preparation of medication).
Information has been received from a pharmacist concerning an 81 year old female inpatient, with drug hypersensitivity  to aspirin and meperidine hydrochloride, and an allergy to penicillin, and a history of dyspnea and hypertension as an emergency, who on 11-Jan-2006 was vaccinated with a second dose of Pneumococcal 23v polysaccharide vaccine. No product quality complain was involved. The patient's present status was reported as unknown.The patient was an inpatient at the hospital at the time of vaccination. It was reported that the patient had been vaccinated two weeks earlier with a dose of Pneumococcal 23v polysaccharide vaccine. No product quality complaint was involved. The patients present status was reported as unknown. Additional information has been requested.
Only received one shot of vaccine; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION IN ERROR (Only received one shot of vaccine) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced PRODUCT DOSE OMISSION IN ERROR (Only received one shot of vaccine). At the time of the report, PRODUCT DOSE OMISSION IN ERROR (Only received one shot of vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
My menstrual cycle was extremely heavy and I passed many large clots, similar to when I had a miscarriage except the heavy bleeding slowed in about 3 days and I completed my menstruation course as usual.
shingles after first dose; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 72-year-old male patient who received Herpes zoster (Shingrix) (batch number 27PA5, expiry date 3rd February 2023) for prophylaxis.   On 27th August 2021, the patient received the 1st dose of Shingrix. On 30th August 2021, 3 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: Pharmacist reported that a patient got 1st dose of Shingrix and presented an active episode of shingles. The reporter consented to follow up.
I developed a small fever and had aches, chills, muscle and joint pain...like the flu. Had some headache pain intermittently. Had to go straight to bed. I was not sure if I would need further medical attention. I slept nearly 12 hours straight, fever was gone in the morning, slept another 4 hours till 1PM 10/30/2010. I am feeling ok now but have residual tiredness and headache.
soreness of left arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INJECTION SITE PAIN (soreness of left arm) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced INJECTION SITE PAIN (soreness of left arm). At the time of the report, INJECTION SITE PAIN (soreness of left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
I had a sore arm right after - starting the next morning after the vaccine. It wasn't extremely sore. I had no fever.  I took Tylenol for the soreness. It stopped after about a week. Approximately 10 days after the vaccine, I developed my polymyalgia symptoms. They flared up - my autoimmune disease. I decided to go back on my Prednisone (I had gotten off of it for taking both doses of the vaccine). I had to take Prednisone for about a month to help with my polymyalgia symptoms. That pretty much too care of it but I took Tylenol and Advil to manage the symptoms after that. My arm continued to be sore. During the whole time, I had a frozen shoulder (since right after the vaccine). Frozen shoulder is just on the one side (which is on area of the vaccination). It wasn't working - or getting better. I called my doctor and went in to see her end of May. I waited a couple of weeks and my shoulder became more frozen. My doctor got me into physical therapy which I have been doing for the past month. I continue to take Tylenol and Advil to manage the symptoms. They polymyalgia symptoms are mostly gone. Just  have some residual stuff but it's going away. As a side note: I have had reactions to vaccines that are a little unusual - that have lasted from 3 days to 3 months (in the past).  I'm about 60% recovered from the frozen shoulder.
Pt received a flu vaccine and upon arrived at home pt with hive, no resp. distress, no cough , no wheeze. Mom gave her a dose of Benadryl with improvement.
Patient appears in office with redness to right thigh and raised area around injection site, with increased itching. Encourage to continue with warm compress and over counter childrens tylenol and motrin. Follow up with PCP for new or worsening conditions. All vitals WNL
S/S redness, swelling, heat, pain at injection site (R) deltoid. Plan: Ibuprofen, warm moist compresses, BENADRYL (or ZYRTEC), anti-itch cream RTC Friday if no better sooner if worsens.
4-5 days later she tested positive for Covid; This is a spontaneous report from a Pfizer sponsored program (patient) reported for herself that: A female patient of unspecified age received first dose of BNT162B2 (PFIZER COVID 19 VACCINE, Solution for injection, Lot number and expiration was not reported) via unspecified route of administration as single for COVID-19 immunization. Medical history and concomitant medication were not provided. It was reported that Caller received 1st dose of Covid vaccine 11Apr and 4-5 days later she tested positive for Covid. Her 2nd dose of the vaccine is supposed to be on Wednesday, and she was wondering if she can take it. Patient underwent lab test and procedure which included SARS-CoV-2 test positive on unspecified date. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained
Tingling, numbness on both arms would change to fingers, legs, toes. Like an electric shock that would come and go. Muscle weakness. Legs would give out under me. Would seem worse when not moving.